Avient Corp
AVNT- Exchange
- NYSE
- Industry
- Plastic Materials, Synth Resins & Nonvulcan Elastomers
- SEC CIK
- 0001122976
No open-market purchases or sales by Avient Corp insiders were filed in the last 90 days; 350 institutions reported holding it in 13F filings for Q2 2026, worth $3.56B in total; ARK Invest is the only superinvestor holding it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 5, 2026, 12:11 AM ET
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 12, 2026 | Feb 13, 2025 | Feb 14, 2024 | Feb 15, 2023 | Feb 8, 2022 |
| Revenue | $3.26B | $3.24B | $3.14B | $3.40B | $4.82B |
| Cost of revenue | $2.24B | $2.18B | $2.25B | $2.51B | $3.72B |
| Gross profit | $1.02B | $1.06B | $892.5M | $882.7M | $1.10B |
| Research and development | $96.7M | $98.7M | $90.3M | $84.9M | $83.2M |
| Selling, general and administrative | $812.1M | $727.4M | $695.7M | $639.4M | $718.4M |
| Operating income | $203.5M | $329.3M | $196.8M | $243.3M | $381.2M |
| Income tax | $28.1M | $54.1M | $11.0M | -$19.3M | $74.0M |
| Net income | $81.9M | $169.5M | $75.7M | $703.1M | $230.8M |
| EPS, basic | $0.90 | $1.86 | $0.83 | $7.71 | $2.53 |
| EPS, diluted | $0.89 | $1.84 | $0.83 | $7.63 | $2.51 |
| Weighted shares, basic | 91.5M | 91.3M | 91.1M | 91.2M | 91.4M |
| Weighted shares, diluted | 91.8M | 92.0M | 91.8M | 92.2M | 92.1M |
| Margins and growth | |||||
| Gross margin | 31.2% | 32.6% | 28.4% | 26.0% | 22.8% |
| Operating margin | 6.2% | 10.2% | 6.3% | 7.2% | 7.9% |
| Net margin | 2.5% | 5.2% | 2.4% | 20.7% | 4.8% |
| Revenue growth, year over year | +0.6% | +3.1% | −7.5% | −29.5% | +48.6% |
| Net income growth, year over year | −51.7% | +123.9% | −89.2% | +204.6% | +75.4% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 12, 2026 | Feb 13, 2025 | Feb 14, 2024 | Feb 15, 2023 | Feb 8, 2022 |
| Accounts receivable | $435.0M | $399.5M | $399.9M | $440.6M | $642.3M |
| Inventory | $367.2M | $346.8M | $347.0M | $372.7M | $461.1M |
| Total current assets | $1.40B | $1.42B | $1.41B | $1.57B | $1.83B |
| Property, plant and equipment | $988.8M | $955.3M | $1.03B | $1.05B | $676.1M |
| Goodwill | $1.76B | $1.66B | $1.72B | $1.67B | $1.29B |
| Intangible assets | $1.49B | $1.45B | $1.59B | $1.60B | $925.2M |
| Total assets | $6.03B | $5.81B | $5.97B | $6.08B | $5.00B |
| Accounts payable | $410.0M | $417.4M | $432.3M | $454.4M | $553.9M |
| Short-term debt | $500.0K | $7.70M | $9.50M | $2.20M | $8.60M |
| Total current liabilities | $846.3M | $756.1M | $773.6M | $869.4M | $940.6M |
| Long-term debt | $1.92B | $2.06B | $2.07B | $2.18B | $1.85B |
| Shareholders' equity | $2.39B | $2.33B | $2.34B | $2.35B | $1.79B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 12, 2026 | Feb 13, 2025 | Feb 14, 2024 | Feb 15, 2023 | Feb 8, 2022 |
| Operating cash flow | $301.6M | $256.8M | $201.6M | $398.4M | $233.8M |
| Capital expenditures | $106.6M | $121.9M | $119.4M | $105.5M | $100.6M |
| Free cash flow | $195.0M | $134.9M | $82.2M | $292.9M | $133.2M |
| Depreciation and amortization | $185.9M | $179.7M | $186.9M | $157.6M | $144.2M |
| Stock-based compensation | $9.10M | $15.4M | $13.2M | $13.2M | $11.2M |
| Dividends paid | $98.8M | $94.0M | $90.2M | $86.8M | $77.7M |
| Share buybacks | – | $0 | $0 | $36.4M | $4.20M |
| Investing cash flow | -$97.0M | -$120.6M | -$94.2M | -$504.0M | -$150.2M |
| Financing cash flow | -$257.1M | -$120.9M | -$201.7M | $166.4M | -$114.6M |
| Net change in cash | -$34.0M | -$1.30M | -$95.3M | $39.9M | -$48.3M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 0.3% | 0.5% | 0.4% | 0.4% | 0.2% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.